University of Nebraska - Lincoln

DigitalCommons@University of Nebraska - Lincoln
Contraception in Wildlife Management

USDA National Wildlife Research Center
Symposia

October 1993

Contraception of Wild and Feral Equids
Jay F. Kirkpatrick
J.W. Turner Jr.
I.K.M. Liu

Follow this and additional works at: https://digitalcommons.unl.edu/nwrccontraception
Part of the Environmental Health and Protection Commons

Kirkpatrick, Jay F.; Turner, J.W. Jr.; and Liu, I.K.M., "Contraception of Wild and Feral Equids" (1993).
Contraception in Wildlife Management. 15.
https://digitalcommons.unl.edu/nwrccontraception/15

This Article is brought to you for free and open access by the USDA National Wildlife Research Center Symposia at
DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Contraception in Wildlife
Management by an authorized administrator of DigitalCommons@University of Nebraska - Lincoln.

Contraception of Wild and Feral Equids
Jay F. Kirkpatrick, J. W.Turner, Jr., and I.K.M. L i u

Abstract: Fertility control in wild horses has been
attempted with both stallions and mares. Nonreversible
surgical sterilization by means of vasectomy has been
successful in inhibiting reproduction in wild horses in
Montana and Nevada. Administration of a microencapsulated
form of testosterone to wild stallions reduced sperm counts
and motilitv and foal counts. In a third ap~roach.lntra~erironea S asttclM rnp ants conla n ng eln.ny esolrao o an0
b ocneo ov, a1 on n w o mares lor D, lo 3
.~roaesterone
years
The first immunological fertility control of free-ranging
wildlife was accomplished with wild horses, Initial experiments demonstrated that immunization with porcine zonae
pellucidae was capable of causing contraception in
domestic mares. Later, contraception was achieved with
the vaccine in free-ranging horses. That study demonstrated that the vaccine (1) could be delivered remotely via
darts, (2) was safe to administer to pregnant animals, and
(3) did not alter social behavior. A followup study revealed
that a single annual booster inoculation would extend the

contraceptive effects for a second year, and the vaccine's
effects are reversible after short-term use.
After 6 years of treating 52 different mares with
porcine zonae pellucidae, contraceptive efficacy exceeded
95 percent. In more recent studies, investigators are studying
the effects of long-term treatment (4 to 7 consecutive years)
upon ovarian function. The orc cine zona Dellucida 1PZPI
vacc ne nas a so probe0 lo oe effect ve n contracepr ng
free roam na fera oonnevs in Vtra n s anos hat onal Parcaptive ~rzewalski'shorses, andbnagers. Tests are
currently under way on 150 feral horses in Nevada for the
purpose of developing a one-inoculation form of the PZP
vaccine that will deliver from 1 to 3 years of contraceDtive
prorecl on An n t al f,e o rest of i n s vacclne no cat& a
n qn oeqree of sbccess LN i n a s na e mot- a1 on o/er a
s ng e Gar and a Ie a test of a second-generalon of
m croca~s~les
a so ino caleo a ntan
- oearee of conlraceD1,ve
efficacyover a single year.
Keywords: equids, immunocontraception, porcine zonae
pellucida, wildlife contraception

Introduction
Over the past 20 years, advances in wildlife contraception have been driven largely by concern over
increases in wild horse (Equus caballus) populations.
Prior to 1971 in North America, wild horse populations
were controlled by the removal of horses from rangeland and their sale for various commercial purposes.
The passage of the Wild Horse and Burro Act (P.L.
92-195) in 1971 by the U.S. Congress provided
almost complete protection to wild and feral equids on
public lands. At the time of the passage of this law,
there were an estimated 17,000 wild horses on U.S.
public lands. In an attempt to provide some form of
population
control, the U.S. Department of the
. .
Interior's Bureau of Land Management, the agency
responsible for management of wild horses in the
United States, initiated the Adopt-a-Horse program.
Horses were gathered and adopted by people interested in acquiring a wild horse. However, the high
cost of this program, its inability to remove sufficiently
large numbers of horses, and increased reproductive
success by the horses remaining on rangelands led to
steady population increases between 1970 and 1980.
By 1980, the estimated number of wild horses on
poublic lands had increased to somewhere between

60,000 and 80,000. Clearly, alternative control
methods were necessary.
Chemically or immunologically induced inhibition
of fertility in equids has been little studied. Historically,
equine fertility control has focused on castration of the
domestic stallion. Most often, this common procedure
is carried out not only to prevent reproduction but also
to reduce testicular androgen production and accompanying aggressive behavior. Recently, interest in
contraception of the equids has increased, largely
because of uncontrolled populations of free-roaming
wild horses and feral burros (E. asinus).

Contraception of the Stallion
Initial attempts at chemical contraception of wild
horses focused on the stallion and attempted to exploit
the haremlike social structure common to the majority
of wild equids. To test the concept, two adult wild
stallions inhabiting the Pryor Mountain Wild Horse
Refuge in Montana were vasectomized and permitted
to return to their bands. After 2 years, no foals appeared
among the mares accompanying the vasectomized
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stallions (Kirkpatrick 1982). When this experiment
was later repeated with larger numbers of wild stallions
in Nevada, the results indicated that dominant stallions
were responsible for the vast majority of successful
breedings (Eagle et al. 1993).
Several potential contraceptive compounds,
including testosterone cypionate, testosterone propionate, quinestrol (17~-ethinylestradiol3-cyclopentyl
ether), 17P estradiol, and a-chlorohydrin (3-chloro1,2-propanediol) were tested in domestic pony
stallions. The a-chlorohydrin led to neurological
disorders, so tests were discontinued. Repeated
intramuscular injections of the two androgens and
quinestrol (1.7 g per 100 kg of body weight, monthly
x 6 months) resulted in significant oligospermia and a
significant reduction in sperm motility, but Silastic
implants contraining estradiol failed to achieve significant reductions in sperm counts, probably because of
poor release rates (Kirkpatrick 1982, Turner and
Kirkpatrick 1982).
A microencapsulated form of testosterone
propionate (mTP) was selected for field tests of
contraceptive efficacy in wild horses in Challis, ID.
The microencapsulation polymer (D,L-lactide) coating
(Southern Research Institute, Birmingham, AL)
permitted a sustained release for up to 6 months after
intramuscular (i.m.) injection. On contact with intercellular water, the lactide coating erodes and releases
the active steroid. The coating is converted to carbon
dioxide and lactic acid.
Fifteen wild stallions-seven experimental
subjects and eight controls-were located by helicopter and darted with approximately 300 mg succinylcholine. After immobilization, stallions received i.m.
injections of 5, 7.5, or 10 g mTP in the hip. Stallion
libido and quantitative aspects of sexual behavior,
based on elimination marking behavior (Turner et al.
1981), were unaffected, and breeding took place.
There was an 83-percent reduction in foal production
compared with mares bred by control stallions (2 v. 13
foals, respectively), with no differences between
fertility and the doses of mTP administered
(Kirkpatrick et al. 1982, Turner and Kirkpatrick 1982).

Concerns for the safety of the stallions, dangers
of immobilization, and high cost of opioid immobilizing
drugs (approximately $50/dose of etorphine and
reversal agent) led to an attempt to deliver 3 g mTP
remotely to wild harem stallions on Assateague Island
National Seashore, by means of barbless darts. In
this study, the stallions were located and darted from
the ground without capture or immobilization. The
pharmacologic success of mTP contraception was
evident; there was a 28.9-percent fertility rate for the
mares accompanying treated stallions and an approximate 45-percent fertility rate among control mares.
However, the difficulties of delivering 3 g mTP in four
separate doses to each stallion were discouraging
(Kirkpatrick and Turner 1987, Turner and Kirkpatrick
1991).

Contraception in the Mare
Steroids
The difficulty of darting a stallion up to four times plus
concerns over band infidelity by mares turned the
focus of wild horse contraception to the mare. Attempts
were made to administer contraceptive doses of
progestins to wild mares. Based on experience with
persistent corpora lutea (Stabenfeldt et al. 1974) and
data which indicated that plasma progesterone
concentrations in excess of 0.5 to 1 ngImL inhibited
ovulation in the mare (Squires et al. 1974, Noden et
al. 1978, Palmer and Jousset 1975), microencapsulated northisterone (norethindrone, mNET) was
administered remotely, with barbless darts, to six wild
mares on Assateague Island (Kirkpatrick and Turner
1987, Turner and Kirkpatrick 1991). This particular
progestin, which had been used successfully to inhibit
fertility in women, was given at a dose of approximately 2 g, in microcapsules similar to those used in
previous studies with testosterone propionate. All six
mares receiving the mNET produced a foal a year
later-a highly improbable event among Assateague
mares, where annual foaling rates seldom exceed 55
percent (Keiper and Houpt 1984).
In another experiment, groups of 30 captive wild
mares in Nevada were each implanted with Silastic
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rods containing 8 g estradiol (E), 24 g progesterone
(P), 8 g E plus 8 g P, 4 g E plus 12 g P, 12 g E plus
12 g P, or no hormone (Vevea et al. 1987, Plotka et al.
1988). Fewer mares receiving 8 g E, 4 g E plus 12 g P,
or 8 g E plus 8 g P displayed estrus, but all animals
displaying estrus-treated or control-ovulated.
These data indicated a rapid decline in plasma steroid
concentrations within 5 weeks of receiving steroid
implants and suggested increased metabolic clearance of the steroid, an event that would also explain
the failure of the mNET treatments described above.
Because of the rapid decline in E and P concentrations, Silastic implants containing the synthetic estrogen ethinylestradiol (EE2) or EE2 plus P were placed
in captive wild mares (Plotka et al. 1989). Animals
pregnant at the time of implantation delivered healthy
foals. Contraceptive efficacy ranged from 88 percent
to 100 percent through two breeding seasons and was
approximately 75 percent for three seasons. Endocrine studies of these mares suggested that contraception occurred by blocking ovulation andlor
implantation.
In a similar study, intraperitoneal implants of 1.5,
3, or 8 g EE2 alone also resulted in contraceptive
efficacy of 75 percent to I 0 0 percent through two
breeding seasons. Rates of EE2 decline in the
plasma suggested a contraceptive life of 16, 26, and
48-60 months for the 1.5-9, 3-9, and 8-9 doses,
respectively (Plotka and Vevea 1990, Eagle et al.
1992).
Results achieved with estradiol, progesterone,
and ethinylestradiol in mares brought to focus advantages and disadvantages of natural versus synthetic
steroids for contraception in equids. Steroids native to
the mare, such as estradiol and progesterone, are
recognized by the mare's metabolic enzymes and
degraded so rapidly that contraceptive doses must be
so large that they are difficult or impossible to administer. The use of some synthetic steroids, such as
ethinylestradiol, may delay metabolic degradation and
permit sustained contraceptive effects and provide
useful fertility inhibition in certain instances. Any risk,
however small, of the passage of these synthetic
steroids to humans or other wildlife may make registration by regulatory agencies such as the Food and

Drug Administration (FDA), the U.S. Department of
Agriculture (USDA), or the Environmental Protection
Agency (EPA) unlikely or difficult.

lmmunocontraception
Attention has turned to immunocontraception because
of (1) the difficulties associated with the delivery of
large doses of microencapsulatedsteroids, (2) dangers
associated with capture and restraint of horses,
(3) surgical procedures associated with intraperitoneal
implants, (4) concern over long-term effects of steroidal contraception, and (5) passage of synthetic
steroids through the food chain. One immunologically
based contraceptive strategy involves blocking the
release of gonadotropin-releasing hormone (GnRH)
from the hypothalamus, thereby preventing pituitary
secretion of follicle-stimulating hormone (FSH) and
luteinizing hormone (LH) and their subsequent tropic
actions on the ovary or testes (Schanbacher 1984).
Immunization of domestic mares against GnRH
blocked ovulation in three of five mares for 4 months
(Safir et al. 1987). Each mare was inoculated with
2 mg of GnRH conjugated to human serum albumin
emulsified in Freund's Complete Adjuvant (FCA).
Analysis of plasma LH revealed a lack of pulsatile
secretion that was correlated with antibody titers. The
high variability in the mares' response to the antigen
and the subsequent variabilities in antibody titers
suggested that this approach was unreliable.
In a study to immunize captive wild mares with
GnRH conjugated to ketolymphohemocyanin (KLH),
either aluminum hydroxide (alum) or monophosphoryl
lipid Ntrehalose 6,6-dimycolatelBCG cell wall skeleton
(triple adjuvant, TA) was used as the adjuvant
(Goodloe et al. 1988). Mares immunized with GnRH
plus TA had higher antibody titers and significantly
less ovarian follicular activity. The vaccine was fieldtested in 29 wild mares on Cumberland Island
National Seashore, in Georgia. The vaccine was
freeze dried and administered as a solid biodegradable 0.25-caliber bullet by means of an air-powered
gun. After imbedding in the tissue of the target mare,
the compressed compound forming the biobullet
degrades over 24 hours, releasing the antigen. A total
of 25 treated mares survived (four died from natural
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causes) and 17 (68 percent) produced foals, which
was not significantly different from foaling rates of
control mares.
Immunization against GnRH has also been
attempted in the stallion (Dowsett et al. 1991). Four
weanling colts were passively immunized, either
intramuscularly or subcutaneously, with an anti-GnRH
antibody (Peptide Technology, Ltd., Sydney, Australia)
and given booster inoculations approximately 75 days
later. Colts immunized intramuscularly maintained
plasma testosterone concentrations of < 0.15 ng/mL
(equivalent to concentrations in geldings) for 5 months
following the booster inoculations. Thereafter, testosterone concentrations rose to control levels for yearlings. Colts immunized subcutaneously had slightly
increased plasma testosterone concentrations (up to
0.37 nglmL) between the two immunizations but
decreased concentrations similar to those seen in the
intramuscularly injected group after the second
inoculation. Antibody titers were generally higher in
the colts immunized intramuscularly, although sexual
development was effectively delayed for 12 months in
both groups of colts.
A second immunocontraception strategy for
equids was based on the identification of antibodies
directed against the zona pellucida of the ovum in
naturally infertile mares (Liu and Shivers 1982) and
immunological cross-reactivity of equine zona-positive
antisera and porcine sperm binding (Shivers and Liu
1982). Liu et al. (1989) immunized 10 captive wild
mares and 4 domestic mares with the protein equivalent of 2,000 to 5,000 porcine zonae pellucidae. FCA
was used for the first inoculation and Freund's Incomplete Adjuvant (FIA) for the three monthly booster
inoculations that followed. Of the 14 treated mares,
13 failed to conceive during the first year. The four
domestic mares all conceived during the second year
after antibody titers decreased.
A field test of the PZP vaccine was carried out on
Assateague Island National Seashore (Kirkpatrick et
al. 1990). For the test, 26 wild mares were remotely
inoculated with approximately 5,000 porcine zonae
pellucidae (65 pg protein) and FCA in March 1988 by
means of barbless darts. The mares received a

second inoculation with PZP + FIA 2 weeks later, and
18 of the mares received a third inoculation with that
combination 1 month later. No foals were produced by
the treated mares, whereas 50 percent of the 6 shaminjected mares (controls) produced foals, and 45
percent of 11 untreated mares produced foals. Posttreatment foaling rate for the PZP-treated mares was
significantly different (P < 0.002) than that for the 2
pretreatment years, for sham-treated control mares
and for untreated mares. Of the 26 PZP-treated
mares, 14 were pregnant at the time of inoculation,
and all 14 produced healthy foals 2-3 months following PZP treatment. Thus, the PZP vaccine had no
effect on pregnancies in progress or the health of the
foals born. Social behaviors and organization were
also unaffected by treatment. Once antigen recognition had taken place, a single annual booster inoculation was sufficient to maintain contraception.
In March 1989, 14 of the previously treated
mares were given a single booster inoculation. A year
later, only one foal was produced. The 12 mares
immunized in 1988 but not given a booster in 1989
produced 5 foals, demonstrating for a second time the
reversibility of the vaccine's contraceptive effects
(Kirkpatrick et al. 1991a). After 6 consecutive years of
booster inoculations among the Assateague mares
and 104 mare-years (the number of mares treated
x the number of years of treatment), four foals have
been produced, for an effectiveness of 96 percent.
Over the 6-year period, the difference between foaling
rates among treated and untreated mares was highly
significant ( P < 0.001).
Field trials were initiated in 1992 with feral
donkeys in Virgin Islands National Park. Sixteen
adult female donkeys received an initial inoculation of
65 yg of porcine zonae pellucidae + FCA, a second
identical inoculation 3 weeks later, and a third 10-12
months later. Eleven untreated adult females were
used as controls. Results were not calculated until
12 months after the initial inoculation in order to allow
for any pregnancies already in progress at the time of
inoculations. Based on observed foals and on fecal
steroid analysis (Kirkpatrick et al. 1991b and c), of the
treated females, only 1 of 16 (6.2 percent) produced a
foal or was pregnant, while among the controls, 6 of
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11 (54.5 percent) produced foals or were pregnant.
The difference between foaling and pregnancy rates
between the two groups was highly significant (P< 0.01).
Large-scale field trials with wild horses were
initiated in December 1992 in Nevada. Slightly more
than 500 wild horses were captured by driving them by
helicopter into a trap and portable corrals. Adult
mares (n = 131) between the ages of 4 and 12 were
included in the study. All mares were freeze-branded
with numbers for later identification. One group
received two inoculations of PZP about 3 weeks apart
with FCA used for the first inoculation and FIA for the
second. A second group received only a single
inoculation + FCA. A third group received a single
inoculation of porcine zonae pellucidae + FCA that
contained another 65 pg of pellucidae in lactideglycolide microspheres. These microspheres were
designed to release the antigen over a 4- to 6-week
period.
During September 1993, fecal samples were
collected from 78 treated or control animals and
analyzed for steroid hormones and steroid hormone
metabolites, which signal pregnancy (Kirkpatrick et al.
1991b and c). Of 27 untreated mares, 14 (52 percent)
were pregnant. Of 17 sham-injected controls, 9 of 17
(53 percent) were pregnant. None of 14 mares
receiving 2 inoculations of porcine zonae pellucidae
were pregnant. Of 20 mares receiving only a single
inoculation of raw pellucidae, 6 (30 percent) were
pregnant. No samples were recovered from mares
receiving the porcine zonae pellucidae in
microspheres.
During June 1994, after aerial foal counts, a total
of 65 experimental mares were observed, and foaling
results were in general agreement with pregnancy
data. From 32 mares that received 2 inoculations,
only a single foal was observed. Of 16 sham-treated
mares, 10 had foals (63 percent), and of 7 mares
receiving only a single inoculation, 3 had foals (43
percent). Of 10 mares receiving a single inoculation
of the microencapsulated porcine zonae pellucidae,
none had foals. These data suggested a contraceptive effect of a single inoculation with microencapsulated porcine zonae pellucidae that lasted 8-9 months
following treatment.

The PZP vaccine has also been tested in captive
exotic equids, including 23 Przewalski's horse (Equus
przewalskii), 1 onager (E. hemionus), and 26 zebra
(E. zebra grevyi) (Kirkpatrick et al. 1992b, 1993).
Thus far, results are available only for the Przewalski's
horses and the onager, and the vaccine has been
100-percent effective in preventing pregnancies in
these species (Kirkpatrick et al. 1993). It is better than
80-percent effective in zebras.
Two important issues are raised with regard to
PZP immunocontraception of equids. The first is the
possibility of long-term effects of the vaccine on
ovarian function. PZP-induced contraception is
thought to be due to a block to fertilization (Liu et al.
1989). At least two of the major glycopreoteins of the
noncellular zona pellucida, ZP3 (Florman and
Wassarman 1985) and ZP4 (Hasagawa et al. 1992),
are necessary components of the receptor molecule
for sperm surface molecules. The role of the ZP3
receptor in the horse has been confirmed in vitro as a
zona pellucida-induced acrosome reaction with horse
sperm (Arns et al. 1991). The initial study of PZP
immunization of horses (Liu et al. 1989) and field tests
with the Assateague wild horses (Kirkpatrick et al.
1990, 1991a) demonstrated that the contraceptive
effects of PZP immunization were reversible after
1 year of treatment. Plasma progesterone concentrations during the year of treatment indicated a luteal
phase and therefore evidence of ovulation. However,
the long-term effects of continuous PZP immunization
have not been described in either the horse or other
species. Reversibility of the contraceptive effect has
been demonstrated in several species but only after
short-term application of the vaccine (Gulyas et al.
1983, Sacco et al. 1987, Liu et al. 1989).
In the dog and the rabbit, PZP immunization
appeared to be very damaging to ovarian follicles and
often led to cessation of ovarian function, with accompanying anovulation and depression of estrogen
concentrations (Wood et al. 1981, Mahi-Brown et al.
1985). Unusually large doses (5,000 pg) caused
anovulation in the baboon (Dunbar et al. 1989).
These data suggested that the antibody response of
the treated animal attacks not only the zona pellucida
of the mature ovum but oocytes and possibly other
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Table 1. Antibody titers in response to porcine zonae pellucidae in domestic mares after one inoculation using
porcine zonae pellucidae plus PZP-containing microspheres or two inoculations of porcine zonae pellucidae given
3 weeks aDart
Dates of inoculation
Treatment

311 3

Horse

412

4116

517

6118

10114

Antibody titers (% of positive reference serum)
FCA-PZP bolus
& PZP microspheres

FCA-PZP bolus +
FIA-PZP bolus
3 weeks later

Aldo
Mia
Imo
Lab
Dee

5
4
6
5
5

99
70
33
38
56

114
107
70
76
108

131
123
95
120
106
--

106
82
98
114
99

79
28
131

Ant
Con
Len
Rou
Sou

4
6
8
3
4

90
66
58
73
67

130
145
118
116
147

131
135
123
133
126

152
144
91
123
136

115
58
35
79
94

FCA = Freund's Complete adjuvant. FIA
adjuvant.

=

Freund's Incomplete

ovarian tissue with resulting changes in estradiol and
progesterone secretion. These effects have not been
demonstrated in the horse after short-term use, but
there is evidence that these same effects may appear
after long-term use.
After 3 consecutive years of PZP treatment,
three of seven Assateague mares showed decreased
urinary estrogen concentrations and no evidence of
ovulation (Kirkpatrick et al. 1992a), and after 6 consecutive years of ovulation, five mares showed no
evidence of ovulation. However, three of these five
mares showed recurring rhythmic estrogen peaks,
suggestive of developing follicular waves, and two of
these five mares demonstrated classical estrous
behavioral concurrent with an estrogen peak and
permitted breeding (Kirkpatrick, unpubl. data). Another
mare demonstrated a luteal-phase urinary progesterone metabolite pattern after 5 consecutive years of
treatment and 1 year off, suggesting that normal
ovarian function returned. The next 3-5 years will
provide critical data regarding the effects of the PZP
vaccine on ovarian function and reversibility after longterm vaccination with porcine zonae pellucidae.
The second critical issue is related to the number
of initial inoculations necessary for contraception.
While it has been clearly established that two inocuia-

tions, given 3-6 weeks apart, will provide contraception for about a year, the need to give two inoculations
decreases the usefulness of the vaccine for wild and
feral equids. Thus, the single most important direction
for future research is the development of a oneinoculation form of the vaccine which provides at least
a full year, and ideally 2-3 years, of contraception
protection.
In an initial attempt to develop a one-inoculation
PZP vaccine, the PZP antigen was incorporated into
nontoxic, biodegradable, 50-p, homogenous lactideglycolide microspheres. Upon i.m. injection, the
iactide-glycolide material erodes, releasing the
anitgen over predetermined periods of time (Eldridge
et al. 1989). The carrier itself is metabolized to lactic
acid and carbon dioxide.
Five domestic mares were inoculated with an
initial bolus of 65 pg of porcine zonae pellucidae +
FCA plus another 65 yg of pellucidae contained in
microspheres. Antibody titers were compared to titers
in mares inoculated with two doses of pellucidae
(65 pg PZPIFCA + 65 pg PZPIFIA) given 3 weeks
apart. Contraceptive antibody titers lasted for approximately 200 days with the one-inoculation preparation
(table 1).
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This same preparation was administered to
14 wild mares on Assateague Island. One dart failed
to inject. That mare, plus only one other mare,
produced foals following treatment. The differences
were significant ( P < 0.05) comparing either 2 foals114
mares or 1 foal113 mares (to account for the failed
dart) with untreated control mares. Similar research is
currently under way to produce a one-inoculation
vaccine using microcapsules. The microcapsules are
made from the same lactide-glycolide material, but
after injection they release the PZP antigen in pulses
rather than continuously.

Conclusions
PZP-induced contraception of the mare may be useful
to prevent unwanted pregnancies among wild and
feral equids. In the case of captive exotic equids,
such as the Przewalski's horse and the zebra, contraception may be useful to prevent the expression of
undesirable genetic traits ("floppy mane" or the fox
allele, for example) or merely to prevent the production of unwanted surplus animals without the need to
remove animals and disrupt well-defined social
groups. Anti-GnRH vaccines may be useful for the
same purpose in the stallion, or simply to reduce
aggression among stallion groups. Finally, contraception may represent a publicly acceptable approach to
the management of wild and feral horses inhabiting
public lands.
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